NCT06285006View on ClinicalTrials.gov

Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 23, 2024

Primary Completion Date

May 1, 2024

Study Completion Date

May 12, 2024

Conditions
Nocturnal Enuresis
Interventions
DRUG

Desmopressin

Desmopressin is a synthetic analogue of ADH released by the posterior pituitary gland that reduces urine production by increasing water reabsorption by the collecting tubules.

Trial Locations (1)

11884

RECRUITING

Alazhar university, Asyut

All Listed Sponsors
lead

Al-Azhar University

OTHER